journal article Open Access Nov 14, 2017

Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis

View at Publisher Save 10.1038/mp.2017.205
Topics

No keywords indexed for this article. Browse by subject →

References
119
[1]
Institute for Health Metrics and Evaluation (IHME) GBD Compare Data Visualization Seattle. IHME, University of Washington: WA, 2016 Available from http://vizhub.healthdata.org/gbd-compare .
[2]
Caraci F, Copani A, Nicoletti F, Drago F . Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 2010; 626: 64–71. 10.1016/j.ejphar.2009.10.022
[3]
Goldsmith DR, Rapaport MH, Miller BJ . A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016; 21: 1696–1709. 10.1038/mp.2016.3
[4]
A Meta-Analysis of Cytokines in Major Depression

Yekta Dowlati, Nathan Herrmann, Walter Swardfager et al.

Biological Psychiatry 2010 10.1016/j.biopsych.2009.09.033
[5]
From inflammation to sickness and depression: when the immune system subjugates the brain

Robert Dantzer, Jason C. O'Connor, Gregory G. Freund et al.

Nature Reviews Neuroscience 2008 10.1038/nrn2297
[6]
Maes M . Evidence for an immune response in major depression: a review and hypothesis. Prog Neuro-psychopharmacol Biol Psychiatry 1995; 19: 11–38. 10.1016/0278-5846(94)00101-m
[7]
Domenici E, Willé DR, Tozzi F, Prokopenko I, Miller S, McKeown A et al. Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS ONE 2010; 5: e9166. 10.1371/journal.pone.0009166
[8]
Young JJ, Silber T, Bruno D, Galatzer-Levy IR, Pomara N, Marmar CR . Is there progress? An overview of selecting biomarker candidates for major depressive disorder. Front Psychiatry 2016; 7: 72.
[9]
Strawbridge R, Arnone D, Danese A, Papadopoulos A, Herane Vives A, Cleare AJ . Inflammation and clinical response to treatment in depression: a meta-analysis. Eur Neuropsychopharmacol 2015; 25: 1532–1543. 10.1016/j.euroneuro.2015.06.007
[10]
Bhattacharya A, Derecki NC, Lovenberg TW, Drevets WC . Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology 2016; 233: 1623–1636. 10.1007/s00213-016-4214-0
[11]
Stuart MJ, Singhal G, Baune BT . Systematic review of the neurobiological relevance of chemokines to psychiatric disorders. Front Cell Neurosci 2015; 9: 357.
[12]
D' Mello C, Le T, Swain MG . Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factorα signaling during peripheral organ inflammation. J Neurosci 2009; 29: 2089. 10.1523/jneurosci.3567-08.2009
[13]
Wohleb ES, Franklin T, Iwata M, Duman RS . Integrating neuroimmune systems in the neurobiology of depression. Nat Rev Neurosci 2016; 17: 497–511. 10.1038/nrn.2016.69
[14]
Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012; 489: 391–399. 10.1038/nature11405
[15]
Marciniak E, Faivre E, Dutar P, Alves Pires C, Demeyer D, Caillierez R et al. The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory. Sci Rep 2015; 5: 15862. 10.1038/srep15862
[16]
Blank T, Detje Claudia N, Spieß A, Hagemeyer N, Brendecke Stefanie M, Wolfart J et al. Brain endothelial- and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment. Immunity 2016; 44: 901–912. 10.1016/j.immuni.2016.04.005
[17]
Cazareth J, Guyon A, Heurteaux C, Chabry J, Petit-Paitel A . Molecular and cellular neuroinflammatory status of mouse brain after systemic lipopolysaccharide challenge: importance of CCR2/CCL2 signaling. J Neuroinflammation 2014; 11: 132. 10.1186/1742-2094-11-132
[18]
Melik-Parsadaniantz S, Rostene W . Chemokines and neuromodulation. J Neuroimmunol 2008; 198: 62–68. 10.1016/j.jneuroim.2008.04.022
[19]
Rostene W, Kitabgi P, Parsadaniantz SM . Chemokines: a new class of neuromodulator? Nat Rev Neurosci 2007; 8: 895–903. 10.1038/nrn2255
[20]
Callewaere C, Banisadr G, Rostene W, Melik-Parsadaniantz S . Chemokines and chemokine receptors in the brain: implication in neuroendocrine regulation. J Mol Endocrinol 2007; 38: 355–363. 10.1677/jme-06-0035
[21]
Rostene W, Guyon A, Kular L, Godefroy D, Barbieri F, Bajetto A et al. Chemokines and chemokine receptors: new actors in neuroendocrine regulations. Front Neuroendocrinol 2011; 32: 10–24. 10.1016/j.yfrne.2010.07.001
[22]
Li M, Ransohoff RM . Multiple roles of chemokine CXCL12in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol 2008; 84: 116–131. 10.1016/j.pneurobio.2007.11.003
[23]
Miller RJ, Rostene W, Apartis E, Banisadr G, Biber K, Milligan ED et al. Chemokine action in the nervous system. J Neurosci 2008; 28: 11792–11795. 10.1523/jneurosci.3588-08.2008
[24]
Williams JL, Holman DW, Klein RS . Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers. Front Cell Neurosci 2014; 8: 154. 10.3389/fncel.2014.00154
[25]
Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, Dijkstra IM et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 2006; 9: 917–924. 10.1038/nn1715
[26]
Delgado PL . Depression: the case for a monoamine deficiency. J Clin Psychiatry 2000; 61: 7–11. 10.4088/jcp.v61n0103
[27]
Hirschfeld RMA . History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61: 4–6.
[28]
Pariante CM, Lightman SL . The HPA axis in major depression: classical theories and new developments. Trends Neurosci 2008; 31: 464–468. 10.1016/j.tins.2008.06.006
[29]
Schoenfeld TJ, Cameron HA . Adult neurogenesis and mental illness. Neuropsychopharmacology 2015; 40: 113–128. 10.1038/npp.2014.230
[30]
Eyre HA, Air T, Pradhan A, Johnston J, Lavretsky H, Stuart MJ et al. A meta-analysis of chemokines in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2016; 68: 1–8. 10.1016/j.pnpbp.2016.02.006
[31]
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Xiang Wan, Wenqian Wang, Jiming Liu et al.

BMC Medical Research Methodology 2014 10.1186/1471-2288-14-135
[32]
Mitchell M Engauge Digitizer Version 7.2. Torrance, California:GNU General Public License Version 2, 2014.
[33]
Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre: The Cochrane Collaboration, 2014.
[34]
Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MNS, Teixeira AL . A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 2012; 53: 797–804. 10.1016/j.comppsych.2011.12.007
[35]
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2013. URL http://www.R-project.org/ .
[36]
Viechtbauer W . Conducting meta-analyses in R with the metafor package. 2010. 2010; 36: 48.
[37]
Fried EI, Kievit RA . The volumes of subcortical regions in depressed and healthy individuals are strikingly similar: a reinterpretation of the results by Schmaal et al. Mol Psychiatry 2016; 21: 724–725. 10.1038/mp.2015.199
[38]
The WEKA data mining software

Mark Hall, Eibe Frank, Geoffrey Holmes et al.

ACM SIGKDD Explorations Newsletter 2009 10.1145/1656274.1656278
[39]
Bai Y-M, Chiou W-F, Su T-P, Li C-T, Chen M-H . Pro-inflammatory cytokine associated with somatic and pain symptoms in depression. J Affect Disord 2014; 155: 28–34. 10.1016/j.jad.2013.10.019
[40]
Bai Y-M, Su T-P, Li C-T, Tsai S-J, Chen M-H, Tu P-C et al. Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls. Bipolar Disord 2015; 17: 269–277. 10.1111/bdi.12259
[41]
Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol 2007; 25: 225–230.
[42]
Blasko I, Lederer W, Oberbauer H, Walch T, Kemmler G, Hinterhuber H et al. Measurement of thirteen biological markers in CSF of patients with alzheimer’s disease and other dementias. Dement Geriatr Cogn Disord 2006; 21: 9–15. 10.1159/000089137
[43]
Byrne ML, O’Brien-Simpson NM, Reynolds EC, Walsh KA, Laughton K, Waloszek JM et al. Acute phase protein and cytokine levels in serum and saliva: A comparison of detectable levels and correlations in a depressed and healthy adolescent sample. Brain Behav Immun 2013; 34: 164–175. 10.1016/j.bbi.2013.08.010
[44]
Cizza G, Marques AH, Eskandari F, Christie IC, Torvik S, Silverman MN et al. Elevated neuroimmune biomarkers in sweat patches and plasma of premenopausal women with major depressive disorder in remission: the POWER Study. Biol Psychiatry 2008; 64: 907–911. 10.1016/j.biopsych.2008.05.035
[45]
Corwin EJ, Pajer K, Paul S, Lowe N, Weber M, McCarthy DO . Bidirectional psychoneuroimmune interactions in the early postpartum period influence risk of postpartum depression. Brain Behav Immun 2015; 49: 86–93. 10.1016/j.bbi.2015.04.012
[46]
Dahl J, Ormstad H, Aass HCD, Malt UF, Bendz LT, Sandvik L et al. The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 2014; 45: 77–86. 10.1016/j.psyneuen.2014.03.019
[47]
Daniele A, Divella R, Abbate I, Giotta F, Trerotoli P, Mautino A et al. Coexistence of an imbalance of cytokines, chemokines and growth factors serum levels and symptoms of fatigue and pain in long-term breast cancer survivors. J Clin Oncol 2015; 33, (15 Suppl); doi: 10.1200/jco.2015.33.15.
[48]
Dantoft TM, Elberling J, Brix S, Szecsi PB, Vesterhauge S, Skovbjerg S . An elevated pro-inflammatory cytokine profile in multiple chemical sensitivity. Psychoneuroendocrinology 2014; 40: 140–150. 10.1016/j.psyneuen.2013.11.012
[49]
Dekker RL, Moser DK, Tovar EG, Chung ML, Heo S, Wu JR et al. Depressive symptoms and inflammatory biomarkers in patients with heart failure. Eur J Cardiovasc Nurs 2014; 13: 444–450. 10.1177/1474515113507508
[50]
Dong T, Zhao X, Yang Z (eds)Concept and approach of human signal-molecular-profiling database: a pilot study on depression using Lab-on-chips. 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); 3–7 July 2013.

Showing 50 of 119 references

Metrics
270
Citations
119
References
Details
Published
Nov 14, 2017
Vol/Issue
23(1)
Pages
48-58
License
View
Cite This Article
S P Leighton, L Nerurkar, R Krishnadas, et al. (2017). Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Molecular Psychiatry, 23(1), 48-58. https://doi.org/10.1038/mp.2017.205